| JNJ | | JOHNSON & JOHNSON | Jennifer L. Taubert | EVP, WWC. Innovative Medicine | Feb 15, 2026 | Tax Payment (Shares) | $243.45 | 1,761 | 428,715 | 194,451 | Feb 18, 2026, 09:11 PM |
| JNJ | | JOHNSON & JOHNSON | Jennifer L. Taubert | EVP, WWC. Innovative Medicine | Feb 15, 2026 | Option/RSU Exercise | - | 3,441 | - | 195,396 | Feb 18, 2026, 09:11 PM |
| JNJ | | JOHNSON & JOHNSON | Jennifer L. Taubert | EVP, WWC. Innovative Medicine | Feb 13, 2026 | Tax Payment (Shares) | $244.55 | 13,956 | 3,412,940 | 192,771 | Feb 18, 2026, 09:11 PM |
| JNJ | | JOHNSON & JOHNSON | Jennifer L. Taubert | EVP, WWC. Innovative Medicine | Feb 13, 2026 | Option/RSU Exercise | - | 28,714 | - | 206,318 | Feb 18, 2026, 09:11 PM |
| JNJ | | JOHNSON & JOHNSON | Jennifer L. Taubert | EVP, WWC. Innovative Medicine | Sep 04, 2025 | Option/RSU Exercise | $101.87 | 56,471 | 5,752,701 | 234,484 | Sep 05, 2025, 06:00 PM |
| JNJ | | JOHNSON & JOHNSON | Jennifer L. Taubert | EVP, WWC. Innovative Medicine | Sep 04, 2025 | Sale | $177.81 | 56,471 | 10,040,883 | 178,013 | Sep 05, 2025, 06:00 PM |
| JNJ | | JOHNSON & JOHNSON | Jennifer L. Taubert | EVP, WWC. Innovative Medicine | Feb 18, 2025 | Tax Payment (Shares) | $156.15 | 651 | 101,654 | 170,459 | Feb 18, 2025, 09:08 PM |
| JNJ | | JOHNSON & JOHNSON | Jennifer L. Taubert | EVP, WWC. Innovative Medicine | Feb 13, 2025 | Option/RSU Exercise | - | 1,302 | - | 167,221 | Feb 18, 2025, 09:08 PM |
| JNJ | | JOHNSON & JOHNSON | Jennifer L. Taubert | EVP, WWC. Innovative Medicine | Feb 14, 2025 | Tax Payment (Shares) | $156.65 | 9,669 | 1,514,635 | 178,013 | Feb 18, 2025, 09:08 PM |
| JNJ | | JOHNSON & JOHNSON | Jennifer L. Taubert | EVP, WWC. Innovative Medicine | Feb 14, 2025 | Option/RSU Exercise | - | 19,518 | - | 185,924 | Feb 18, 2025, 09:08 PM |
| JNJ | | JOHNSON & JOHNSON | Jennifer L. Taubert | EVP, WWC. Innovative Medicine | Feb 15, 2025 | Option/RSU Exercise | - | 1,594 | - | 171,110 | Feb 18, 2025, 09:08 PM |
| JNJ | | JOHNSON & JOHNSON | Jennifer L. Taubert | EVP, WWC. Innovative Medicine | Feb 07, 2025 | Option/RSU Exercise | $100.06 | 58,504 | 5,853,910 | 213,355 | Feb 11, 2025, 07:41 PM |
| JNJ | | JOHNSON & JOHNSON | Jennifer L. Taubert | EVP, WWC. Innovative Medicine | Feb 07, 2025 | Tax Payment (Shares) | $153.12 | 47,436 | 7,263,400 | 165,919 | Feb 11, 2025, 07:41 PM |
| JNJ | | JOHNSON & JOHNSON | Jennifer L. Taubert | EVP, WWC. Innovative Medicine | Feb 13, 2024 | Tax Payment (Shares) | $157.85 | 666 | 105,128 | 154,851 | Feb 15, 2024, 04:53 PM |
| JNJ | | JOHNSON & JOHNSON | Jennifer L. Taubert | EVP, WWC. Innovative Medicine | Feb 13, 2024 | Option/RSU Exercise | - | 1,302 | - | 155,517 | Feb 15, 2024, 04:53 PM |
| JNJ | | JOHNSON & JOHNSON | Jennifer L. Taubert | EVP, WWC. Innovative Medicine | Feb 12, 2024 | Tax Payment (Shares) | $157.40 | 13,403 | 2,109,632 | 154,215 | Feb 14, 2024, 06:36 PM |
| JNJ | | JOHNSON & JOHNSON | Jennifer L. Taubert | EVP, WWC. Innovative Medicine | Feb 12, 2024 | Option/RSU Exercise | - | 26,202 | - | 167,618 | Feb 14, 2024, 06:36 PM |
| JNJ | | JOHNSON & JOHNSON | Jennifer L. Taubert | EVP, WW Chair, Pharmaceuticals | Feb 09, 2024 | Sale | $156.27 | 59,397 | 9,281,969 | 141,416 | Feb 12, 2024, 07:25 PM |
| JNJ | | JOHNSON & JOHNSON | Jennifer L. Taubert | EVP, WW Chair, Pharmaceuticals | Feb 08, 2024 | Tax Payment (Shares) | $156.33 | 1,913 | 299,059 | 141,416 | Feb 12, 2024, 07:25 PM |
| JNJ | | JOHNSON & JOHNSON | Jennifer L. Taubert | EVP, WW Chair, Pharmaceuticals | Feb 08, 2024 | Option/RSU Exercise | - | 3,739 | - | 143,329 | Feb 12, 2024, 07:25 PM |
| JNJ | | JOHNSON & JOHNSON | Jennifer L. Taubert | EVP, WW Chair, Pharmaceuticals | Feb 09, 2024 | Option/RSU Exercise | $90.44 | 59,397 | 5,371,865 | 200,813 | Feb 12, 2024, 07:25 PM |
| JNJ | | JOHNSON & JOHNSON | Jennifer L. Taubert | EVP, WW Chair, Pharmaceuticals | Feb 13, 2023 | Tax Payment (Shares) | $162.01 | 10,569 | 1,712,284 | 139,590 | Feb 15, 2023, 07:25 PM |
| JNJ | | JOHNSON & JOHNSON | Jennifer L. Taubert | EVP, WW Chair, Pharmaceuticals | Feb 10, 2023 | Option/RSU Exercise | - | 3,570 | - | 130,026 | Feb 14, 2023, 04:36 PM |
| JNJ | | JOHNSON & JOHNSON | Jennifer L. Taubert | EVP, WW Chair, Pharmaceuticals | Feb 10, 2023 | Tax Payment (Shares) | $162.08 | 1,289 | 208,921 | 128,737 | Feb 14, 2023, 04:36 PM |
| JNJ | | JOHNSON & JOHNSON | Jennifer L. Taubert | EVP, WW Chair, Pharmaceuticals | Nov 22, 2022 | Option/RSU Exercise | $72.54 | 76,923 | 5,579,994 | 203,379 | Nov 23, 2022, 04:44 PM |
| JNJ | | JOHNSON & JOHNSON | Jennifer L. Taubert | EVP, WW Chair, Pharmaceuticals | Nov 22, 2022 | Sale | $176.78 | 76,923 | 13,598,372 | 126,456 | Nov 23, 2022, 04:44 PM |
| JNJ | | JOHNSON & JOHNSON | Jennifer L. Taubert | EVP, WW Chair, Pharmaceuticals | Feb 15, 2022 | Tax Payment (Shares) | $165.89 | 8,841 | 1,466,633 | 126,456 | Feb 17, 2022, 06:01 AM |
| JNJ | | JOHNSON & JOHNSON | Jennifer L. Taubert | EVP, WW Chair, Pharmaceuticals | Feb 15, 2022 | Option/RSU Exercise | - | 18,064 | - | 135,297 | Feb 17, 2022, 06:01 AM |
| JNJ | | JOHNSON & JOHNSON | Jennifer L. Taubert | EVP, WW Chair, Pharmaceuticals | Feb 14, 2022 | Tax Payment (Shares) | $168.85 | 1,190 | 200,932 | 117,233 | Feb 15, 2022, 08:02 PM |
| JNJ | | JOHNSON & JOHNSON | Jennifer L. Taubert | EVP, WW Chair, Pharmaceuticals | Feb 14, 2022 | Option/RSU Exercise | - | 3,297 | - | 118,423 | Feb 15, 2022, 08:02 PM |
| JNJ | | JOHNSON & JOHNSON | Jennifer L. Taubert | EVP, WW Chair, Pharmaceuticals | Feb 12, 2021 | Tax Payment (Shares) | $165.55 | 6,065 | 1,004,061 | 120,394 | Feb 17, 2021, 07:09 PM |
| JNJ | | JOHNSON & JOHNSON | Jennifer L. Taubert | EVP, WW Chair, Pharmaceuticals | Feb 12, 2021 | Option/RSU Exercise | - | 13,606 | - | 121,191 | Feb 17, 2021, 07:09 PM |
| JNJ | | JOHNSON & JOHNSON | Jennifer L. Taubert | EVP, WW Chair, Pharmaceuticals | Feb 13, 2020 | Tax Payment (Shares) | $150.46 | 8,228 | 1,237,985 | 111,862 | Feb 18, 2020, 05:03 PM |
| JNJ | | JOHNSON & JOHNSON | Jennifer L. Taubert | EVP, WW Chair, Pharmaceuticals | Feb 13, 2020 | Option/RSU Exercise | - | 16,084 | - | 115,813 | Feb 18, 2020, 05:03 PM |
| JNJ | | JOHNSON & JOHNSON | Jennifer L. Taubert | EVP, WW Chair, Pharmaceuticals | Feb 03, 2020 | Tax Payment (Shares) | $149.32 | 23,721 | 3,542,020 | 99,729 | Feb 04, 2020, 07:31 PM |
| JNJ | | JOHNSON & JOHNSON | Jennifer L. Taubert | EVP, WW Chair, Pharmaceuticals | Feb 03, 2020 | Option/RSU Exercise | - | 48,312 | - | 123,450 | Feb 04, 2020, 07:31 PM |
| JNJ | | JOHNSON & JOHNSON | Jennifer L. Taubert | EVP, WW Chair, Pharmaceuticals | Feb 08, 2019 | Option/RSU Exercise | - | 8,529 | - | 72,205 | Feb 12, 2019, 09:15 PM |
| JNJ | | JOHNSON & JOHNSON | Jennifer L. Taubert | EVP, WW Chair, Pharmaceuticals | Feb 11, 2019 | Tax Payment (Shares) | $131.94 | 6,236 | 822,778 | 73,751 | Feb 12, 2019, 09:15 PM |
| JNJ | | JOHNSON & JOHNSON | Jennifer L. Taubert | EVP, WW Chair, Pharmaceuticals | Feb 11, 2019 | Option/RSU Exercise | - | 9,748 | - | 78,388 | Feb 12, 2019, 09:15 PM |
| JNJ | | JOHNSON & JOHNSON | Jennifer L. Taubert | EVP, WW Chair, Pharmaceuticals | Feb 08, 2019 | Tax Payment (Shares) | $132.00 | 3,565 | 470,580 | 68,640 | Feb 12, 2019, 09:15 PM |